FDG PET imaging in sarcoidosis

Seminars in Nuclear Medicine

Volumn 43, Issue 6, 2013, Pages 404-411

  Sobic Saranovic, Dragana ^a   Artiko, Vera ^a   Obradovic, Vladimir ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM 67; INFLIXIMAB; PREDNISOLONE;

ARTICLE; BIOPSY; CHRONIC DISEASE; DISEASE MARKER; HUMAN; IMAGING; LYMPHOMA; PARAAORTIC LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; RADIATION EXPOSURE; SARCOIDOSIS; SPLEEN; SYMPTOM; TREATMENT RESPONSE;

CHRONIC DISEASE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; POSITRON-EMISSION TOMOGRAPHY; SARCOIDOSIS;

EID: 84885151227     PISSN: 00012998     EISSN: 15584623     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2013.06.007     Document Type: Article

References (67)

1. G.W. Hunninghake, U. Costabel, and M. Ando ATS/ERS/ WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of sarcoidosis and other granulomatous disorders Sarcoidosis Vasc Diffuse Lung Dis 16 1999 149 173
2. M.C. Iannuzzi, B.A. Rybicki, and A.S. Teirstein Sarcoidosis N Engl J Med 357 2007 2153 2165
3. A.S. Morgenthau, and M.C. Iannuzzii Recent advances in sarcoidosis Chest 139 2011 174 182
4. C.E. Cox, A. Davis-Allen, and M.A. Judson Sarcoidosis Med Clin North Am 89 2005 817 828
5. J. Mana, and C. Game Molecular imaging in sarcoidosis Curr Opin Pulm Med 17 2011 325 331
6. D.S. McGrath, P.J. Foley, and M. Petrek Ace gene I/D polymorphism and sarcoidosis pulmonary disease severity Am J Respir Crit Care Med 164 2001 197 201
7. S. Malaisamy, B. Dalal, and C. Bimenyuy The clinical and radiologic features of nodular pulmonary sarcoidosis Lung 187 2009 9 15
8. M. Akira, T. Kozuka, and Y. Inoue Long-term follow-up CT scan evaluation in patients with pulmonary sarcoidosis Chest 127 2005 185 191
9. R. Lebtahi, B. Crestani, and N. Belmatoug Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis J Nucl Med 42 2001 21 26
10. D.M. Schuster, and N. Alazraki Gallium and other agents in diseases of the lung Semin Nucl Med 32 2002 193 211
11. C. Love, M.B. Thomas, and C.J.T. Palestro FDG PET of infection and inflammation Radiographics 25 2005 1357 1368
12. T.C. Kwee, D.A. Torigian, and A. Alavi Nononcological applications of positron emission tomography for evaluation of thorax J Thorac Imaging 28 2013 25 39
13. T. Mochizuk, E. Tsukamoto, and Y. Kuge FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models J Nucl Med 42 2001 1551 1555
14. Y. Rosen Pathology of sarcoidosis Semin Respir Crit Care Med 28 2007 36 52
15. R.G.M. Keijsers, D.A.F. van den Heuvel, and J.C. Grutters Imaging the inflammatory activity of sarcoidosis Eur Respir J 41 2013 743 751
16. P.J. Lewis, and A. Salama Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis J Nucl Med 35 1994 1647 1649
17. A. Alavi Is there a role for FDG PET imaging in the management of patients with sarcoidosis? J Nucl Med 35 1994 1650 1652
18. A.S. Teirstein, J. Machac, and O. Almeida Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis Chest 132 2007 1949 1953
19. S. Kruger, A.K. Buck, and M. Mottaghy Use of integrated FDG-PET/CT in sarcoidosis Clin Imaging 32 2008 269 273
20. J.G. Scadding Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation Br J Med 2 1961 1165 1172
21. L.E. Siltzbach Sarcoidosis: Clinical features and management Med Clin North Am 51 1967 483 502
22. E. Criado, M. Sanchez, and J. Ramirez Pulmonary sarcoidosis: Typical and atypical manifestations at high resolution CT with pathological correlation Radiographics 30 2010 1567 1586
23. M. Remy-Jardin, J. Remy, and C. Deffontaines Assessment of diffuse infiltrative lung disease: Comparison of conventional CT and high-resolution CT Radiology 181 1991 157 162
24. J.R. Mayo, W.R. Webb, and R. Gould High-resolution CT of the lungs: An optimal approach Radiology 163 1987 507 510
25. N.L. Müller, and R.R. Miller Ground-glass attenuation, nodules, alveolitis, and sarcoid granulomas Radiology 189 1993 31 32
26. R.L.M. Mostard, S. Voo, and M.J. van Kroonenburgh Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis Respir Med 105 2011 1917 1924
27. 18F-FDG PET activity in sarcoidosis Respir Med 107 2013 439 447
28. 18F-FDG PET as a predictor of pulmonary function in sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis 28 2011 123 129
29. 18F-FDG PET patterns and BAL cell profiles in pulmonary sarcoidosis Eur J Nucl Med Mol Imaging 37 2010 1181 1188
30. M. Drent, J.A. Jacobs, and J. de Vries Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis? Eur Resp J 13 1999 1338 1344
31. 18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis Eur J Nucl Med Mol Imaging 36 2009 1131 1137
32. 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis J Nucl Med 53 2012 1543 1549
33. 67Ga scintigraphy in patients with sarcoidosis J Nucl Med 47 2006 1571 1576
34. 67Ga-citrate in sarcoidosis imaging Nuklearmedizin 47 2008 18 23
35. 18F-FDG PET Q J Nucl Med Mol Imaging 55 2011 66 71
36. V. Vardhanabhuti, N. Venkatanarasimha, and G. Bhathagar Extra-pulmonary manifestation of sarcoidosis Clin Radiol 67 2012 263 276
37. A. Westers-Attema, J.C. Veraart, and C.D. de Pont PET scan findings in a patients with severe cutaneous and systemic sarcoidosis Clin Nucl Med 36 2011 1049 1050
38. J. Holmes, and A. Lazarus Sarcoidosis: Extrathoracic manifestation Dis Mon 55 2009 675 692
39. 18F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis. Results of preliminary prospective study Clin Nucl Med 38 2013 e171 e177
40. N. De Prost, K. Kerrou, and M. Sibony Fluorine-18 fluorodeoxyglucose with positron emission tomography revealed bone marrow involvement in sarcoidosis patients with anaemia Respiration 79 2010 25 31
41. C. Aberg, F. Ponzo, and B. Raphael FDG positron emission tomography of bone involvement in sarcoidosis AJR Am J Roentgenol 182 2004 975 977
42. V. Ludwig, S. Fordice, and R. Lammar Unsuspected skeletal sarcoidosis mimicking metastatic disease on FDG positron emission tomography and bone scintigraphy Clin Nucl Med 28 2003 176 179
43. R.L. Mostard, L. Prompers, and R.E. Weijers F-18 FDG PET/CT for detecting bone and bone marrow involvement in sarcoidosis patients Clin Nucl Med 37 2012 21 25
44. V. Terushkin, B.J. Stern, and M.A. Judson Neurosarcoidosis, presentations and management Neurologist 16 2010 2 15
45. K.M. Lury, M.G. Smith, and M.G. Matheous Neurosarcoidosis: Review of imaging findings Semin Roentgenol 39 2004 495 504
46. N. Dubey, R.S. Miletich, and M. Wasay Role of fluorodeoxyglucose positron emission tomography in the diagnosis of neurosarcoidosis J Neurol Sci 205 2002 77 81
47. S. Bartels, L. Kyavar, and N. Blumstein FDG PET findings leading to diagnosis of neurosarcoidosis Clin Neurol Neurosurg 115 2013 85 88
48. K. Suga, N. Matsunaga, and K. Yasuhiko F-18 FDG PET/CT findings in a case of spinal cord sarcoidosis Clin Nucl Med 36 2011 382 385
49. K. Sakushima, I. Yabe, and T. Shiga FDG-PET SUV can distinguish between spinal sarcoidosis and myelopathy with canal stenosis J Neurol 258 2011 227 230
50. A. Perry, and F. Vuitch Causes of death in patients with sarcoidosis: A morphologic study of 38 autopsies with clinicopathologic correlations Arch Pathol Lab Med 119 1995 167 172
51. 18F-fluoro-2-doexyglucoe positron emission tomography and magnetic resonance imaging in sarcoidosis Eur J Nucl Med Mol Imaging 35 2008 933 941
52. 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis Eur Heart J 26 2005 1538 1543
53. 18F-FDG PET in the diagnosis of cardiac sarcoidosis: A systematic review and meta analysis including the Ontario experience J Nucl Med 53 2012 241 248
54. N.Y. Hamzeh, F.S. Wamboldt, and H.D. Weinberger Management of cardiac sarcoidosis in the United States. A Delphi study Chest 141 2012 154 162
55. 18F-FDG PET/CT in sarcoidosis management: Review and report of 20 cases Eur J Nucl Med Mol Imaging 35 2008 1537 1543
56. K. Kaira, T. Ishizuka, and N. Yanagitani Value of FDG positron emission tomography in monitoring the effects of therapy in progressive pulmonary sarcoidosis Clin Nucl Med 32 2007 114 116
57. 18F-FDG PET and early metabolic response to corticosteroid therapy Br J Radiol 80 2007 e67 e71
58. D. Sobic Saranovic, I. Grozdic, and J. Videnovic-Ivanov Responsiveness of FDG PET/CT to treatment of patients with active chronic sarcoidosis Clin Nucl Med 38 2013 516 521
59. 18F-FDG PET in sarcoidosis: An observation study in 12 patients treated with infiximab Sarcoidosis Vasc Diffuse Lung Dis 25 2008 143 150
60. L. Kostakoglu, H. Agress Jr., and S.J. Goldsmith Clinical role of FDG PET in evaluation of cancer patients Radiographics 23 2003 315 340
61. T. Koyama, H. Ueda, and K. Togashi Radiologic manifestation of sarcoidosis in various organs Radiographics 24 2004 87 104
62. D.M. Warshauer, and J.K. Lee Imaging manifestation of abdominal sarcoidosis AJR Am J Roentgenol 182 2004 15 28
63. 18F fluorodeoxyglucose positron emission tomography scan due to sarcoid reaction following induction chemotherapy for lung cancer Jpn J Thorac Cardiovasc Surg 53 2005 196 198
64. H.B. Prabhakar, C.B. Rabinowitz, and F.K. Gibbons Imaging features of sarcoidosis on MCT, FDG PET and PET/CT AJR Am J Roentgenol 190 2008 S1 S6
65. H. Brinker The sarcoidosis-lymphoma syndrome Br J Cancer 54 1986 467 473
66. N. Suvajdzic, B. Milenkovic, and M. Perunicic Two cases of sarcoidosis-lymphoma syndrome Med Oncol 24 2007 469 471
67. 18F-FDG PET/CT examinations J Nucl Med 46 2005 608 613